Abstract
Children with respiratory diseases take treatments for the self-management of symptoms and to maintain disease control. Often, these treatments need to be taken in social environments like school. Respiratory treatments can foster a feeling of difference and stigmatisation, which negatively impact on the quality of life and adherence to treatment. Such perceptions can lead to a less than optimal disease control, a vicious cycle leading to further social exclusion and stigma. This aspect of “burden of treatment” is poorly recognised by clinicians. Recognition of how treatments and clinical practice can contribute to stigma, can help address this burden of care.
Cite
CITATION STYLE
Kansra, S., Calvert, R., & Jones, S. (2021, March 1). Stigma from medication use: An under recognised burden of care. Breathe. European Respiratory Society. https://doi.org/10.1183/20734735.0002-2021
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.